These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18903)

  • 1. Dopamine-stimulated adenylate cyclase in rat substantia nigra: localization and effects of neuroleptics.
    Spano PF; Di Chiara G; Loddo P; Tonon GC; Trabucchi M
    Adv Biochem Psychopharmacol; 1977; 16():613-6. PubMed ID: 18903
    [No Abstract]   [Full Text] [Related]  

  • 2. A dopamine-stimulated adenylate cyclase in rat substantia nigra.
    Spano PF; Di Chiara G; Tonon GC; Trabucchi M
    J Neurochem; 1976 Dec; 27(6):1565-8. PubMed ID: 1003232
    [No Abstract]   [Full Text] [Related]  

  • 3. Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra.
    Bockaert J; Premont J; Glowinski J; Tassin JP; Thierry AM
    Adv Biochem Psychopharmacol; 1977; 16():29-37. PubMed ID: 196489
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclic AMP in retina and caudate nucleus: influence of dopamine and other agents.
    Makman MH; Brown JH; Mishra RK
    Adv Cyclic Nucleotide Res; 1975; 5():661-79. PubMed ID: 165691
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for the existence of regulatory DA receptors in the substantia nigra.
    Di Chiara G; Mereu GP; Vargiu L; Porceddu ML; Mulas A; Trabucchi M; Spano PF
    Adv Biochem Psychopharmacol; 1977; 16():477-81. PubMed ID: 18896
    [No Abstract]   [Full Text] [Related]  

  • 6. Amine-responsive adenylate cyclase activity from brain: comparisons between rat and rhesus monkey and demonstration of dopamine-stimulated adenylate cyclase in monkey neocortex.
    Weinryb I; Michel IM
    Psychopharmacol Commun; 1976; 2(1):39-48. PubMed ID: 822479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation by dopamine of adenosine cyclic 3',5'-monophosphate formation in rat caudate nucleus: effect of lesions of the nigro-neostriatal pathway.
    Krueger BK; Forn J; Walters JR; Roth RH; Greengard P
    Mol Pharmacol; 1976 Jul; 12(4):639-48. PubMed ID: 183096
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of alpha, beta, and dopamine receptor-blocking agents on the stimulation of rat erythrocyte adenyl cyclase by dihydroxyphenethylamines and their beta-hydroxylated derivatives.
    Sheppard H; Burghardt CR
    Mol Pharmacol; 1971 Jan; 7(1):1-7. PubMed ID: 5552248
    [No Abstract]   [Full Text] [Related]  

  • 9. The activity of substituted benzamides in biochemical models of dopamine receptors.
    Kebabian JW; Tsuruta K; Cote TE; Grewe CW
    Adv Biochem Psychopharmacol; 1982; 35():17-49. PubMed ID: 6293277
    [No Abstract]   [Full Text] [Related]  

  • 10. Zetidoline, a novel neuroleptic, activates nigral dopaminergic neurons in rats.
    Mereu G; Fanni B; Collu M; Diena A; Glasser A
    Life Sci; 1985 Feb; 36(5):459-64. PubMed ID: 2857469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenylate cyclase from various dopaminergic areas of the brain and the action of antipsychotic drugs.
    Clement-Cormier YC; Robison GA
    Biochem Pharmacol; 1977 Sep; 26(18):1719-22. PubMed ID: 20110
    [No Abstract]   [Full Text] [Related]  

  • 12. Is the dopamine sensitive adenylate cyclase in the rat substantia nigra coupled with 'autoreceptors'?
    Premont J; Thierry AM; Tassin JP; Glowinski J; Blanc G; Bockaert J
    FEBS Lett; 1976 Sep; 68(1):99-104. PubMed ID: 964385
    [No Abstract]   [Full Text] [Related]  

  • 13. N-oxides of phenothiazine antipsychotics: effects on in vivo and in vitro estimates of dopaminergic function.
    Lewis MH; Widerlöv E; Knight DL; Kilts CD; Mailman RB
    J Pharmacol Exp Ther; 1983 Jun; 225(3):539-45. PubMed ID: 6134814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
    Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment.
    Clement-Cormier Y
    Adv Biochem Psychopharmacol; 1980; 24():103-11. PubMed ID: 6105768
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence for increased dopamine receptor binding in superresponsive mice after a single dose of neuroleptics.
    Hyttel J
    Adv Biochem Psychopharmacol; 1980; 24():167-73. PubMed ID: 6105773
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic neuroleptic therapy: tolerance and GABA systems.
    Lloyd KG; Shibuya M; Davidson L; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1977; 16():409-15. PubMed ID: 18890
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
    Gnegy ME; Bernabei A; Treisman G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.